2021 Virtual ARThritis Soirée Raises Over $315,000 to Benefit Vital Arthritis Research
The 8th annual ARThritis Soirée was a huge success, raising over $315,000 to fund life-changing arthritis research for over 6 million Canadians living with the pain and disability of 100+ rheumatic diseases.
The ARThritis Soirée is the signature event of Arthritis Research Canada, the largest clinical arthritis research centre in North America. Although guests weren’t able to gather in-person, this year’s virtual format allowed people from across Canada and beyond to attend for the first time.
Guests were treated to fabulous performances by Bill Henderson of Chilliwack, Neil Osborne of 54-40, Josh Ramsay of Marianas Trench and Rosemary Siemens and Eli Bennett of SaxAndViolin. These award-winning musicians all gave their time and talents in support of arthritis research.
The Soirée’s success is thanks to the collective and generous efforts of sponsors, guests, donors, volunteers, performers and our dynamic co-hosts: Coleen Christie of Global BC and Mike Reno of Loverboy.
“Many people don’t realize that arthritis is a term used to describe over 100 diseases that can strike at any age,” said Dr. Diane Lacaille, Arthritis Research Canada’s scientific director. “Arthritis isn’t just about aches and pains. It is serious and even life-threatening in some cases.”
Arthritis Research Canada is grateful for Macdonald Realty and Macdonald Commercial’s three years of support as Presenting Sponsor of the ARThritis Soirée.
“By supporting arthritis research, we believe we can make a lasting impact in the lives of millions of people,” said Dan Scarrow, President of Macdonald Real Estate Group. “Arthritis is an invisible and misunderstood disease and the Soirée is an opportunity to raise awareness and funds for arthritis research and bring change to the way people live with pain and disability.”
Arthritis Research Canada is conducting over 100 studies to reduce the burden of arthritis. This research is focused on arthritis prevention, facilitating early diagnosis, new and better treatments, and improving quality of life.
To learn more about our current research projects, please click here.
